Case Studies
- 31 March 2010
Case Study - Manufacturing
Supply Chain Risk Management The Facts PharmX has one blockbuster, BB1 (over $1 billion in annual sales), and several other important (over $100 million) products - DR1, DR2, DR3, DR4 - in their portfolio. Their supply chain is similar to those of ...
READ FULL STUDY - 31 March 2010
Case Study - Regulatory Affairs
Incomplete FDA New Drug Application (NDA) Data Submission The Facts PharmX has pending NDA's on some novel medications. It utilizes the services of six different Clinical Research Organizations (CROs) to administer its Phase 3 clinical trials, whi...
READ FULL STUDY - 31 March 2010
Case Study - Commercial
Product Recall The Facts PharmX is a global company that manufactures and sells a variety of injectible pharmaceutical products. It has several manufacturing facilities around the world and also employs toll manufacturers. It sells its products in ...
READ FULL STUDY
